Takahashi K, Manabe A, Okada M, et al. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas. 2000;34:169-177.
Minaguchi H, Uemura T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.
J Obstet Gynaecol Res. 1996;22:259-265.
Itoi H, Minakami H, Sato I. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women.
Maturitas. 1997;28:11-17.
Hayashi T, Ito I, Kano H, et al. Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women.
J Gerontol A Biol Sci Med Sci. 2000;55:B183-B190.
Dugal R, Hesla K, Sordal T, et al. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
Acta Obstet Gynecol Scand. 2000;79:293-297.
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
N Engl J Med. 1993;329:753-756.
van der Linden MC, Gerretsen G, Brandhorst MS, et al. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms.
Eur J Obstet Gynecol Reprod Biol. 1993;51:29-33.
Holland EF, Leather AT, Studd JW. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
Br J Obstet Gynaecol. 1995;102:238-242.
Nozaki M, Hashimoto K, Inoue Y, et al. Usefulness of estriol for the treatment of bone loss in postmenopausal women [in Japanese; English abstract].
Nippon Sanka Fujinka Gakkai Zasshi. 1996;48:83-88.
Minaguchi H, Uemura T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.
J Obstet Gynaecol Res. 1996;22:259-265.
Takahashi K, Manabe A, Okada M, et al. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas. 2000;34:169-177.
Lemon HM, Kumar PF, Peterson C, et al. Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen.
Cancer. 1989;63:1685-1692.
Lemon HM, Wotiz HH, Parsons L, et al. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy.
JAMA. 1966;196:1128-1136.
Lemon HM. Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma.
Acta Endocrinol Suppl (Copenh).
1980;233:17-27.
Granberg S, Ylostalo P, Wikland M, et al. Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding.
Maturitas. 1997;27:35-40.
Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Lancet. 1999;353:1824-1828.
Montoneri C, Zarbo G, Garofalo A, et al. Effects of estriol administration on human postmenopausal endometrium.
Clin Exp Obstet Gynecol. 1987;14:178-181.
Takahashi K, Manabe A, Okada M, et al. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas. 2000;34:169-177.
Punnonen R, Soderstrom KO. The effect of oral estriol succinate therapy on the endometrial morphology in postmenopausal women: the significance of fractionation of the dose.
Eur J Obstet Gynecol Reprod Biol. 1983;14:217-224.
Lippman M, Monaco ME, Bolan G. Effects of estrone, estradiol and estriol on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res. 1977;37:1901-1907.
Vooijs GP, Geurts TB. Review of the endometrial safety during intravaginal treatment with estriol.
Eur J Obstet Gynecol Reprod Biol. 1995;62:101-106.
Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Lancet. 1999;353:1824-1828.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.